Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: A contribution to the choice of anaesthetic

British Journal of Pharmacology

Volumn 157, Issue 8, 2009, Pages 1474-1482

  Kurz, C M ^a   Baranowska, U ^a   Lupinski S ^b   Gothert M ^a,b   Malinowska, B ^b   Schlicker, E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

3H Na methylhistamine binding; 3H noradrenaline release; 3H rauwolscine binding; 3H rimonabant binding; A2 adrenoceptor; CB1 receptor; H3 receptor; Pentobarbitone anaesthesia; Pithed rat; Urethane anaesthesia

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALPHA 2 ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; HISTAMINE H3 RECEPTOR; IMETIT; PENTOBARBITAL; PRESYNAPTIC RECEPTOR; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; NORADRENALIN RELEASE; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANESTHETICS; ANIMALS; CARDIOVASCULAR SYSTEM; CEREBRAL CORTEX; CYCLOHEXANOLS; DECEREBRATE STATE; ELECTRIC STIMULATION; HISTAMINE AGONISTS; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; PENTOBARBITAL; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, PRESYNAPTIC; THIOUREA; URETHANE; VASOCONSTRICTOR AGENTS;

EID: 70350342278     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00315.x     Document Type: Article

References (32)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2): S1-S209.
2. Armstrong JM, Boura ALA (1973). Effects of clonidine and guanethi-dine on peripheral sympathetic nerve function in the pithed rat. Br J Pharmacol 47: 850-852.
3. Armstrong JM, Lefèvre-Borg F, Scatton B, Cavero I (1982). Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther 223: 524-535.
4. Baranowska U, Göthert M, Rudź R, Malinowska B (2008). Methanan-damide allosterically inhibits in vivo the function of peripheral nicotinic acetylcholine receptors containing the a7 subunit. J Pharmacol Exp Ther 326: 912-919.
5. Boyland E, Rhoden E (1949). The distribution of urethane in animal tissues, as determined by a microdiffusion method, and the effect of urethane treatment on enzymes. Biochem J 44: 528-531.
6. Christopoulos A, Kenakin T (2002). G protein-coupled receptor allos-terism and complexing. Pharmacol Rev 54: 323-374.
7. Gifford AN, Tang Y, Gatley SJ, Volkow ND, Lan R, Makriyannis A (1997). Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci Lett 238: 84-86.
8. Godlewski G, Malinowska B, Buczko W, Schlicker E (1997). Inhibitory H3 receptors on sympathetic nerves of pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats. Naunyn-Schmiedebergs Arch Pharmacol 355: 261-266.
9. Hara K, Harris HA (2002). The anesthetic mechanism of urethane: its effects on inhibitory and excitatory neurotransmitter receptors. Anesth Analg 94: 313-318.
10. Hatanaka T, Sato S, Endoh M, Katayama K, Kakemi M, Koizumi T (1988). Effect of chlorpromazine on the pharmacokinetics and pharmacodynamics of pentobarbital in rats. J Pharmacobiodynam 11: 18-30. (Pubitemid 18062170)
11. Ishac EJN, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996). Inhibition of exocytotic nordrenaline release by presynaptic can-nabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118: 2023-2028.
12. Kathmann M, Schlicker E, Detzner M, Timmerman H (1993). Nordi-maprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model. Naunyn-Schmiedebergs Arch Pharmacol 348: 498-503.
13. Kathmann M, Bauer U, Schlicker E, Göthert M (1999). Cannabinoid CB1 receptor-mediated inhibition of NMDA-and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn-Schmiedebergs Arch Pharmacol 359: 466-470.
14. Limberger N, Trendelenburg AU, Starke K (1995). Subclassification of presynaptic a2-adrenoceptors: a2D-autoreceptors in mouse brain. Naunyn-Schmiedebergs Arch Pharmacol 352: 43-48.
15. Maggi CA, Meli A (1986a). Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: cardiovascular system. Experientia 42: 292-297.
16. Maggi CA, Meli A (1986b). Suitability of urethane anesthesia for phys-iopharmacological investigations in various systems. Part 1: general considerations. Experientia 42: 109-114.
17. Malinowska B, Schlicker E (1991). H3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur J Pharmacol 205: 307-310.
18. Malinowska B, Piszcz J, Koneczny B, Hryniewicz A, Schlicker E (2001). Modulation of sympathetic and parasympathetic transmission to the heart of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors. Naunyn-Schmiedebergs Arch Pharmacol 364: 233-241.
19. O'Flaherty EJ, Sichak P (1983). The kinetics of urethane elimination in the mouse. Toxicol Appl Pharmacol 68: 354-358.
20. Schlicker E, Göthert M (1998). Interactions between the presynaptic a2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47: 129-132.
21. Schlicker E, Fink K, Hinterthaner M, Göthert M (1989). Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmiedebergs Arch Pharmacol 340: 633-638.
22. Schlicker E, Lümmen G, Behling A, Göthert M (1992a). Inhibition of noradrenaline release via NEM-sensitive H3 receptors in the mouse brain cortex: more marked effect than in the rat brain. Agents Actions 36: (Suppl. 2): C339-C342.
23. Schlicker E, Behling A, Lümmen G, Göthert M (1992b). Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 345: 489-493.
24. Schlicker E, Behling A, Lümmen G, Malinowska B, Göthert M (1992c). Mutual interaction of histamine H3-receptors and a2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 345: 639-646.
25. Schlicker E, Kathmann M, Exner HJ, Detzner M, Göthert M (1994). The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of a2-adrenoceptors in the mouse brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 349: 20-24.
26. Schlicker E, Redmer A, Werner A, Kathmann M (2003). Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release. Brit J Pharmacol 140: 323-328.
27. Shimokawa A, Kunitake T, Takasaki M, Kannan H (1998). Differential effects of anesthetics on sympathetic nerve activity and arterial baroreceptor reflex in chronically instrumented rats. J Auton Nerv Syst 72: 46-54.
28. Shipley RE, Tilden JH (1947). A pithed rat preparation suitable for assaying pressor substances. Proc Soc Exp Biol Med 64: 453-455.
29. Trendelenburg AU, Limberger N, Starke K (1993). Presynaptic a2-autoreceptors in brain cortex: a2D in the rat and a2A in the rabbit. Naunyn-Schmiedebergs Arch Pharmacol 348: 35-45.
30. Trendelenburg AU, Cox SL, Schelb V, Klebroff W, Khairallah L, Starke K (2000). Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and b-adrenoceptors in mouse tissues. Br J Pharmacol 130: 321-330.
31. Weitzell R, Tanaka T, Starke K (1979). Pre-and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedebergs Arch Pharmacol 308: 127-136.
32. Wixson SK, Smiler SL (1997). Anesthesia and analgesia in rodents. In: Kohn DF, Wixson SK, White WJ, Benson GJ (eds). Anesthesia and Analgesia in Laboratory Animals. Academic Press: New York, p. 165-203.